Treatment with the Olive Secoiridoid Oleacein Protects against the Intestinal Alterations Associated with EAE

Multiple sclerosis (MS) is a CNS inflammatory demyelinating disease. Recent investigations highlight the gut-brain axis as a communication network with crucial implications in neurological diseases. Thus, disrupted intestinal integrity allows the translocation of luminal molecules into systemic circ...

Full description

Bibliographic Details
Main Authors: Beatriz Gutiérrez-Miranda, Isabel Gallardo, Eleni Melliou, Isabel Cabero, Yolanda Álvarez, Marta Hernández, Prokopios Magiatis, Marita Hernández, María Luisa Nieto
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/5/4977
_version_ 1797615094748676096
author Beatriz Gutiérrez-Miranda
Isabel Gallardo
Eleni Melliou
Isabel Cabero
Yolanda Álvarez
Marta Hernández
Prokopios Magiatis
Marita Hernández
María Luisa Nieto
author_facet Beatriz Gutiérrez-Miranda
Isabel Gallardo
Eleni Melliou
Isabel Cabero
Yolanda Álvarez
Marta Hernández
Prokopios Magiatis
Marita Hernández
María Luisa Nieto
author_sort Beatriz Gutiérrez-Miranda
collection DOAJ
description Multiple sclerosis (MS) is a CNS inflammatory demyelinating disease. Recent investigations highlight the gut-brain axis as a communication network with crucial implications in neurological diseases. Thus, disrupted intestinal integrity allows the translocation of luminal molecules into systemic circulation, promoting systemic/brain immune-inflammatory responses. In both, MS and its preclinical model, the experimental autoimmune encephalomyelitis (EAE) gastrointestinal symptoms including “leaky gut” have been reported. Oleacein (OLE), a phenolic compound from extra virgin olive oil or olive leaves, harbors a wide range of therapeutic properties. Previously, we showed OLE effectiveness preventing motor defects and inflammatory damage of CNS tissues on EAE mice. The current studies examine its potential protective effects on intestinal barrier dysfunction using MOG<sub>35-55</sub>-induced EAE in C57BL/6 mice. OLE decreased EAE-induced inflammation and oxidative stress in the intestine, preventing tissue injury and permeability alterations. OLE protected from EAE-induced superoxide anion and accumulation of protein and lipid oxidation products in colon, also enhancing its antioxidant capacity. These effects were accompanied by reduced colonic IL-1β and TNFα levels in OLE-treated EAE mice, whereas the immunoregulatory cytokines IL-25 and IL-33 remained unchanged. Moreover, OLE protected the mucin-containing goblet cells in colon and the serum levels of iFABP and sCD14, markers that reflect loss of intestinal epithelial barrier integrity and low-grade systemic inflammation, were significantly reduced. These effects on intestinal permeability did not draw significant differences on the abundance and diversity of gut microbiota. However, OLE induced an EAE-independent raise in the abundance of <i>Akkermansiaceae</i> family. Consistently, using Caco-2 cells as an in vitro model, we confirmed that OLE protected against intestinal barrier dysfunction induced by harmful mediators present in both EAE and MS. This study proves that the protective effect of OLE in EAE also involves normalizing the gut alterations associated to the disease.
first_indexed 2024-03-11T07:21:38Z
format Article
id doaj.art-81bbc17dc73b41a9a9691bb0ccc11006
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T07:21:38Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-81bbc17dc73b41a9a9691bb0ccc110062023-11-17T07:56:02ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-03-01245497710.3390/ijms24054977Treatment with the Olive Secoiridoid Oleacein Protects against the Intestinal Alterations Associated with EAEBeatriz Gutiérrez-Miranda0Isabel Gallardo1Eleni Melliou2Isabel Cabero3Yolanda Álvarez4Marta Hernández5Prokopios Magiatis6Marita Hernández7María Luisa Nieto8Instituto de Biomedicina y Genética Molecular de Valladolid (IBGM-CSIC/UVa), 47003 Valladolid, SpainInstituto de Biomedicina y Genética Molecular de Valladolid (IBGM-CSIC/UVa), 47003 Valladolid, SpainLaboratory of Pharmacognosy and Natural Products Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, GreeceInstituto de Biomedicina y Genética Molecular de Valladolid (IBGM-CSIC/UVa), 47003 Valladolid, SpainInstituto de Biomedicina y Genética Molecular de Valladolid (IBGM-CSIC/UVa), 47003 Valladolid, SpainLaboratorio de Biología Molecular y Microbiología, Instituto Tecnológico Agrario de Castilla y León (ITACyL), 47071 Valladolid, SpainLaboratory of Pharmacognosy and Natural Products Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, GreeceInstituto de Biomedicina y Genética Molecular de Valladolid (IBGM-CSIC/UVa), 47003 Valladolid, SpainInstituto de Biomedicina y Genética Molecular de Valladolid (IBGM-CSIC/UVa), 47003 Valladolid, SpainMultiple sclerosis (MS) is a CNS inflammatory demyelinating disease. Recent investigations highlight the gut-brain axis as a communication network with crucial implications in neurological diseases. Thus, disrupted intestinal integrity allows the translocation of luminal molecules into systemic circulation, promoting systemic/brain immune-inflammatory responses. In both, MS and its preclinical model, the experimental autoimmune encephalomyelitis (EAE) gastrointestinal symptoms including “leaky gut” have been reported. Oleacein (OLE), a phenolic compound from extra virgin olive oil or olive leaves, harbors a wide range of therapeutic properties. Previously, we showed OLE effectiveness preventing motor defects and inflammatory damage of CNS tissues on EAE mice. The current studies examine its potential protective effects on intestinal barrier dysfunction using MOG<sub>35-55</sub>-induced EAE in C57BL/6 mice. OLE decreased EAE-induced inflammation and oxidative stress in the intestine, preventing tissue injury and permeability alterations. OLE protected from EAE-induced superoxide anion and accumulation of protein and lipid oxidation products in colon, also enhancing its antioxidant capacity. These effects were accompanied by reduced colonic IL-1β and TNFα levels in OLE-treated EAE mice, whereas the immunoregulatory cytokines IL-25 and IL-33 remained unchanged. Moreover, OLE protected the mucin-containing goblet cells in colon and the serum levels of iFABP and sCD14, markers that reflect loss of intestinal epithelial barrier integrity and low-grade systemic inflammation, were significantly reduced. These effects on intestinal permeability did not draw significant differences on the abundance and diversity of gut microbiota. However, OLE induced an EAE-independent raise in the abundance of <i>Akkermansiaceae</i> family. Consistently, using Caco-2 cells as an in vitro model, we confirmed that OLE protected against intestinal barrier dysfunction induced by harmful mediators present in both EAE and MS. This study proves that the protective effect of OLE in EAE also involves normalizing the gut alterations associated to the disease.https://www.mdpi.com/1422-0067/24/5/4977multiple sclerosisEAEoleaceinintestinal permeabilityinflammation
spellingShingle Beatriz Gutiérrez-Miranda
Isabel Gallardo
Eleni Melliou
Isabel Cabero
Yolanda Álvarez
Marta Hernández
Prokopios Magiatis
Marita Hernández
María Luisa Nieto
Treatment with the Olive Secoiridoid Oleacein Protects against the Intestinal Alterations Associated with EAE
International Journal of Molecular Sciences
multiple sclerosis
EAE
oleacein
intestinal permeability
inflammation
title Treatment with the Olive Secoiridoid Oleacein Protects against the Intestinal Alterations Associated with EAE
title_full Treatment with the Olive Secoiridoid Oleacein Protects against the Intestinal Alterations Associated with EAE
title_fullStr Treatment with the Olive Secoiridoid Oleacein Protects against the Intestinal Alterations Associated with EAE
title_full_unstemmed Treatment with the Olive Secoiridoid Oleacein Protects against the Intestinal Alterations Associated with EAE
title_short Treatment with the Olive Secoiridoid Oleacein Protects against the Intestinal Alterations Associated with EAE
title_sort treatment with the olive secoiridoid oleacein protects against the intestinal alterations associated with eae
topic multiple sclerosis
EAE
oleacein
intestinal permeability
inflammation
url https://www.mdpi.com/1422-0067/24/5/4977
work_keys_str_mv AT beatrizgutierrezmiranda treatmentwiththeolivesecoiridoidoleaceinprotectsagainsttheintestinalalterationsassociatedwitheae
AT isabelgallardo treatmentwiththeolivesecoiridoidoleaceinprotectsagainsttheintestinalalterationsassociatedwitheae
AT elenimelliou treatmentwiththeolivesecoiridoidoleaceinprotectsagainsttheintestinalalterationsassociatedwitheae
AT isabelcabero treatmentwiththeolivesecoiridoidoleaceinprotectsagainsttheintestinalalterationsassociatedwitheae
AT yolandaalvarez treatmentwiththeolivesecoiridoidoleaceinprotectsagainsttheintestinalalterationsassociatedwitheae
AT martahernandez treatmentwiththeolivesecoiridoidoleaceinprotectsagainsttheintestinalalterationsassociatedwitheae
AT prokopiosmagiatis treatmentwiththeolivesecoiridoidoleaceinprotectsagainsttheintestinalalterationsassociatedwitheae
AT maritahernandez treatmentwiththeolivesecoiridoidoleaceinprotectsagainsttheintestinalalterationsassociatedwitheae
AT marialuisanieto treatmentwiththeolivesecoiridoidoleaceinprotectsagainsttheintestinalalterationsassociatedwitheae